DOVA PHARMACEUTICALS INC's ticker is DOVA and the CUSIP is 25985T102. A total of 65 filers reported holding DOVA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 15.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,458,000 | +2.5% | 52,187 | -48.3% | 0.00% | 0.0% |
Q2 2019 | $1,423,000 | +183.5% | 100,939 | +502.1% | 0.00% | +100.0% |
Q2 2018 | $502,000 | +103.2% | 16,765 | +64.7% | 0.00% | – |
Q3 2017 | $247,000 | -79.6% | 10,182 | -81.3% | 0.00% | -100.0% |
Q2 2017 | $1,212,000 | – | 54,365 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 3,708,705 | $103,658,000 | 2.79% |
ALPINE ASSOCIATES MANAGEMENT INC. | 1,419,100 | $39,664,000 | 1.30% |
Birchview Capital, LP | 50,000 | $1,398,000 | 0.93% |
Yakira Capital Management, Inc. | 40,000 | $1,118,000 | 0.33% |
WATER ISLAND CAPITAL LLC | 140,000 | $3,913,000 | 0.24% |
TUDOR INVESTMENT CORP ET AL | 138,700 | $3,877,000 | 0.13% |
GW&K Investment Management, LLC | 330,621 | $9,241,000 | 0.13% |
Weiss Asset Management LP | 50,000 | $1,398,000 | 0.11% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 33,000 | $922,000 | 0.10% |
Polar Asset Management Partners Inc. | 200,000 | $5,590,000 | 0.10% |